This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Voskaridou, E. Articles by Terpos, E. Search for Related Content PubMed PubMed Citation Articles by Voskaridou, E. Articles by Terpos, E.

Pulmonary hypertension in patients with sickle cell/ß thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations

From the Thalassemia Center, Laikon General Hospital, Athens, Greece (EV, ES); Department of Echocardiographic Studies, Bioiatriki Medical Center, Athens, Greece (GT); Department of Medical Research, 251 General Airforce Hospital, Athens, Greece (AT, DC, ET)

Correspondence: Ersi Voskaridou, Thalassemia Center, Laikon General Hospital, 16 Sevastoupoleos street, GR-11526, Athens, Greece. E-mail: ersi_voskaridou{at}yahoo.com

Background and Objectives: Pulmonary hypertension (PH) is increasingly observed in sickle cell disease (SCD) and ß-thalassemia (ß-thal), but there is no information on its prevalence in patients with HbS/ß-thal. The amino-terminal fragment of B-type natriuretic peptide (NT-proBNP) is considered as an independent prognostic factor in PH. The aim of this study was to evaluate the incidence of PH and its correlation with clinical and laboratory findings, including NT-proBNP, in patients with HbS/ß-thal.

Design and Methods: We studied 84 HbS/ß-thal patients; 51% had been receiving hydroxyurea for a median time of 9 years. The presence of PH was evaluated using Doppler echocardiography and NT-proBNP serum levels were determined by an electrochemiluminescence immunoassay.

Results: The incidence of PH in our cohort of HbS/ß-thal patients was 33%. PH patients had elevated values of NT-proBNP, reticulocyte counts and serum ferritin compared with patients without PH. However, even patients without PH had elevated concentrations of NT-proBNP compared with controls. An NT-proBNP level of 153.6 pg/mL had the highest sensitivity (85.7%) and specificity (94.6%) for detecting PH in our patients. NT-proBNP levels correlated with measures of pulmonary artery systolic pressure (tricuspid regurgitant jet velocity and right ventricular systolic pressure), left atrial area and diastolic dysfunction. The administration of hydroxyurea did not affect the presence of PH.

Interpretation and Conclusions: The incidence of PH in patients with HbS/ß-thal is similar to that observed in patients with SCD. Serum NT-proBNP is a strong indicator of PH in HbS/ß-thal. The correlation between PH and reticulocyte counts and ferritin suggests that the degree of hemolysis and iron overload is implicated in the pathogenesis of PH in HbS/ß-thal.

Key words: pulmonary hypertension, sickle cell disease, ß-thalassemia, HbS/ß-thalassemia, amino-terminal B-type natriuretic peptide, NT-proBNP.

This article has been cited by other articles:

				V. R. Gordeuk, A. Campbell, S. Rana, M. Nouraie, X. Niu, C. P. Minniti, C. Sable, D. Darbari, N. Dham, O. Onyekwere, et al. Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease Blood, November 19, 2009; 114(21): 4639 - 4644. [Abstract] [Full Text] [PDF]

				A. C. Frei, Y. Guo, D. W. Jones, K. A. Pritchard Jr, K. A. Fagan, N. Hogg, and N. J. Wandersee Vascular dysfunction in a murine model of severe hemolysis Blood, July 15, 2008; 112(2): 398 - 405. [Abstract] [Full Text] [PDF]